Expanding Liver Transplant Opportunities in Older Patients With Nonconventional Grafts

J Surg Res. 2023 Aug:288:140-147. doi: 10.1016/j.jss.2023.01.017. Epub 2023 Mar 24.

Abstract

Introduction: Broader use of donation after circulatory death (DCD) and nonconventional grafts for liver transplant helps reduce disparities in organ availability. Limited data, however, exists on outcomes specific to nonconventional graft utilization in older patients. As such, this study aimed to investigate outcomes specific to conventional and nonconventional graft utilization in recipients > 70 y of age.

Methods: 1-to-3 matching based on recipient sex, Model for End-Stage Liver Disease score, and donor type was performed on patients ≥70 and <70 y of age who underwent liver transplant alone at Mayo Clinic Arizona between 2015 and 2020. Primary outcomes were posttransplant patient and liver allograft survival for recipients greater than or less than 70 y of age. Secondary outcomes included grafts utilization patterns, hospital length of stay, need for reoperation, biliary complications and disposition at time of hospital discharge.

Results: In this cohort, 36.1% of grafts came from DCD donors, 17.4% were postcross clamp offers, and 20.8% were nationally allocated. Median recipient ages were 59 and 71 y (P < 0.01). Recipients had similar Intensive care unit (P = 0.82) and hospital (P = 0.14) lengths of stay, and there were no differences in patient (P = 0.68) or graft (P = 0.38) survival. When comparing donation after brain death and DCD grafts in those >70 y, there were no differences in patient (P = 0.89) or graft (P = 0.71) survival.

Conclusions: Excellent outcomes can be achieved in older recipients, even with use of nonconventional grafts. Expanded use of nonconventional grafts can help facilitate transplant opportunities in older patients.

Keywords: Age; Deceased donor; Donor pool; Graft type; Marginal donor; Organ shortage.

MeSH terms

  • Aged
  • Death
  • End Stage Liver Disease* / surgery
  • Graft Survival
  • Humans
  • Liver Transplantation*
  • Retrospective Studies
  • Severity of Illness Index
  • Tissue Donors
  • Tissue and Organ Procurement*